Site-Specific Conjugation to Cys-Engineered THIOMAB™ Antibodies
- PMID: 31643049
- DOI: 10.1007/978-1-4939-9929-3_4
Site-Specific Conjugation to Cys-Engineered THIOMAB™ Antibodies
Abstract
Antibodies bearing engineered cysteine residues (termed THIOMAB™ antibodies) enable the site-selective attachment of a drug, label or other payload for specific delivery to certain tissues (e.g., tumors). This Chapter describes detailed methods we have developed and optimized for the conjugation, purification and analysis of THIOMAB™ antibody drug conjugates (TDCs).
Keywords: ADC; Disulfide; Engineered cysteine; Maleimide; Site-specific conjugation; THIOMAB.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
